Skip to main content
. 2024 Aug 5;32(12):3141–3150. doi: 10.1002/ksa.12384

Table 3.

Primary outcome data: T2 relaxation time.

ESWT group (n = 14) p Valuea Control group (n = 13) p Valuea
Pretreatmentb 32.1 ± 2.9 30.2 ± 3.2
6 monthsb 30.4 ± 3.4 <0.001 30.9 ± 3.3 n.s.
12 monthsb 29.4 ± 3.5 <0.001 31.2 ± 3.0 n.s.

Abbreviations: ESWT, extracorporeal shockwave therapy; n.s., not significant.

a

Paired‐sample t‐test with reference to pretreatment.

b

Values are presented as mean ± SD.